DREXEL UNIVERSITY COLLEGE OF MEDICINE;IMCLONE LLC;UNIVERSITY OF WASHINGTON
发明人:
LOIZOS, NICK,HUBER, JIM
申请号：
HK10102590.8
公开号：
HK1135917B
申请日:
2008.07.28
申请国别(地区):
HK
年份:
2014
代理人:
摘要：
The present invention concerns an effective amount of a PDGFR± antagonist for use as a medicament for treating subjects having a bone tumor and also for inhibiting growth of a bone tumor. The PDGFR± antagonist may be an antibody or antibody fragment. In certain embodiments the antagonist can be a bispecific antibody.
